Table 4 Medians for each disease group: recommendations rated as “uncertain” overalla
Recommendation | Overall median | Mean absolute deviation from the median (MADM) | Median amongst mental health panellists N = 5 | Median amongst cancer panellists N = 6 | Median amongst heart failure panellists N = 5 | |
|---|---|---|---|---|---|---|
39 | The main objectives of MDT meetings should be the same across all chronic diseases | 6.5 | 1.88 | 3 | 7 | 7 |
40 | Teaching should be a function of MDT meetings provided it does not add to the length of meetings | 6.5 | 2.31 | 8 | 6 | 5 |
41 | Teaching should be a function of MDT meetings even if it means meetings will be longer | 5 | 1.94 | 7 | 6 | 4 |
42 | All treatment plans for existing patients should be agreed in an MDT meeting even if a clear protocol exists | 5 | 2.06 | 7 | 5 | 2 |
43 | Members should be allowed to not attend as long as someone from their discipline is attending and the member does not have a case to present | 5 | 1.75 | 7 | 4.5 | 6 |
44 | A list of people who are required to attend the MDT meeting should be decided locally by the team | 5 | 2.44 | 6 | 2 | 7 |
45 | A patient should only be discussed at the MDT meeting when information on comorbidity is available | 4.5 | 2.19 | 2 | 6 | 6 |
46 | A designated MDT member should speak to the patient about comorbidities before the patient is discussed at an MDT meeting | 4 | 2.38 | 6 | 3.5 | 3 |
47 | Each MDT should identify the most appropriate methods for presenting complete information on comorbidities | 5 | 1.13 | 7 | 5 | 5 |
48 | Case presentation should routinely include a brief introduction of the patient and relevant psychosocial characteristics, otherwise the case should not be discussed | 6 | 2.38 | 7 | 4 | 3 |
49 | Any MDT member who presents a case should discuss treatment preferences with the patient before the MDT meeting | 5.5 | 2.00 | 7 | 4.5 | 7 |
50 | Patient preferences regarding available treatment options should be discussed with the patient after (rather than before) the MDT meeting | 5.5 | 1.63 | 5 | 6 | 8 |
51 | Patients should not be presented at the MDT meeting unless there is someone present who has met with them at least once before the meeting, even if this postpones discussion of that patient | 5 | 2.63 | 8 | 2 | 3 |
52 | Patients should be given the opportunity to provide information in advance of the MDT meeting to ensure the information presented is accurate and comprehensive | 5 | 2.13 | 7 | 4.5 | 6 |
53 | Patients should be able to provide information by having direct access and the ability to modify their medical records | 5 | 2.69 | 7 | 2 | 5 |
54 | Patients should be given the option to provide a written summary for the meeting | 5 | 1.88 | 6 | 3.5 | 3 |
55 | Patients should be given the option to provide audio recorded input to the meeting | 4.5 | 2.50 | 7 | 1.5 | 3 |